Actively Recruiting
The Use of Rhythmic Light Therapy in Mild Cognitive Impairment
Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-01-05
20
Participants Needed
1
Research Sites
29 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this within-subjects, crossover study, participants will undergo Electroencephalogram (EEG) recordings before, during, and after each of three 1-hour sessions. All participants will experience all three conditions: (1) dual-frequency visual (10 and 40 Hz), (2) single-frequency visual (40 Hz), and (3) non-rhythmic stimulation. EEG spectral power and amplitude coupling will be analyzed to determine whether stimulation-induced increases in alpha-gamma neural synchrony translate to improvements in cognitive performance.
CONDITIONS
Official Title
The Use of Rhythmic Light Therapy in Mild Cognitive Impairment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History of Mild Cognitive Impairment with a Montreal Cognitive Assessment score between 18 and 25
- Age between 55 and 80 years
You will not qualify if you...
- History of epilepsy or photosensitivity
- Blindness or other obstructive vision conditions
- Retinal diseases
- Presence of another brain disease accounting for their cognitive status
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
B
Barbara Plitnick
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here